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Abstract Recent reports have indicated that mesenchymal stromal cells (MSCs) from bone marrow have a potential in vascular
remodeling and angiogenesis. Here, we report a unique phenomenon that under serum-deprived conditions MSCs survive and replicate.
Secretome analysis of MSCs grown under serum-deprived conditions (SD-MSCs) identified a significant upregulation of prosurvival and
angiogenic factors including VEGF-A, ANGPTs, IGF-1, and HGF. An ex vivo rat aortic assay demonstrated longer neovascular sprouts
generated from rat aortic rings cultured in SD-MSC-conditioned media compared to neovascular sprouts from aortas grown in MSC-
conditioned media. With prolonged serum deprivation, a subpopulation of SD-MSCs began to exhibit an endothelial phenotype. This
population expressed endothelial-specific proteins including VEGFR2, Tie2/TEK, PECAM/CD31, and eNOS and also demonstrated the
ability to uptake acetylated LDL. SD-MSCs also exhibited enhancedmicrotubule formation in an in vitro angiogenesis assay. Modified chick
chorioallantoic membrane (CAM) angiogenesis assays showed significantly higher angiogenic potential for SD-MSCs compared to MSCs.
Analysis of CAMs grown with SD-MSCs identified human-specific CD31-positive cells in vascular structures. We conclude that under the
stress of serum deprivation MSCs are highly angiogenic and a population of these cells has the potential to differentiate into endothelial-
like cells.
© 2011 Elsevier B.V. All rights reserved.Introduction
Mesenchymal stem cells (MSCs) are plastic adherent cells from bone
marrow [1,2], referred to in the hematological literature as marrowAbbreviations: MSC, mesenchymal stem cell; SD-MSC, serum-
deprived mesenchymal stem cell; acLDL, acetylated low-density
lipoprotein; grBME, growth factor reduced basement membrane
extract; CAM, chorioallantoic membrane; FBS, fetal bovine serum;
CCM, cell culture media containing serum; SF-CCM, serum-free cell
culture media.
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1873-5061/$ – see front matter © 2011 Elsevier B.V. All rights reserved
doi:10.1016/j.scr.2011.01.004stromal cells. MSCs were first defined as fibroblastoid colony
forming units (CFU-Fs), then as mesenchymal stem/progenitor
cells, and most recently as multipotent mesenchymal stromal cells
[3]. The angiogenic potential of these cells is an area of current
interest. Recent studies have demonstrated a role for MSCs in
promoting angiogenesis following tissue injury in several disease
models, including myocardial infarction, stroke, hind limb ischemia,
and diabetes [4–10]. In addition, MSCs have been shown to function
as stromal cells in solid tumors [11] and vascular stromal cells in
wound healing models [12,13]. The proangiogenic effects of MSCs
have been attributed to their ability to secrete cytokines and
growth factors that promote endogenous angiogenesis [5–7,9], as
well as their ability to contribute directly to angiogenesis through
differentiation [6,8,12,13].
One of the properties of stem cells is to survive and support
endogenous cells during adverse conditions [14]. In vitro studies.
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Figure 1 SD-MSCs continue to proliferate and secrete proteins
under serum-free conditions: (A) Time course study of MSC
growth in media containing 17% serum (CCM) and in serum-free
media (SF). The average of 3 culture replicates is shown with SD.
(B) Immunoblot of culture media conditioned by SD-MSCs on Day
30 of serum deprivation.
216 A. Oskowitz et al.have demonstrated that MSCs upregulate prosurvival and angiogenic
factors, including HGF, IGF-1, and VEGF-A, when exposed to
inflammatory cytokines [15]. Studies from our laboratory have
demonstrated that complete serum deprivation of MSCs for more
than 3 weeks selects a subpopulation of MSCs that are likely
primitive uncommitted cells [16]. Accordingly, we set out to test
the hypothesis that in response to serum deprivation, MSCs display
survival properties characterized by the secretion of prosurvival and
angiogenic factors, and that these factors can act in an autocrine,
paracrine, or juxtacrine mechanism to enhance angiogenesis.
Results
MSCs survive and replicate during serum deprivation
We began by assessing cell proliferation rates of serum-deprived
MSCs (SD-MSCs) from two different donors. MSCs were grown to 70%
confluence in cell culture media containing serum (CCM) and then
the media were replaced with serum-free cell culture media (SF-
CCM), containing only amino acids and glucose, creating a nutrient-
deprived state. The number of surviving SD-MSCs was determined
sequentially over a period of 80 days, at 5 to 10 day intervals (Fig. 1)
using trypan blue to exclude dead cells in the total cell count.
Initially there was a rapid decrease in the surviving cells soon after
cells were placed in SF-CCM. However, around Day 5 of nutrient
deprivation the cells began to proliferate again. SD-MSCs continued
to proliferate for approximately 30 days. After 30 days, cell numbers
remained static, indicating minimal levels of cell replication. The
remaining SD-MSCs were able to survive for up to 1 year in SF-CCM.
SD-MSCs upregulate a variety of angiogenic factors
Next, we hypothesized that in response to serum deprivation, SD-
MSCs secrete a number of factors that act in an autocrine manner to
support cell growth. Initial cytokine and growth factor immunoblots
demonstrated significant expression of prosurvival and angiogenic
factors in conditioned media from SD-MSCs (Fig. 2A), while control
unconditioned media showed no signal. Microarray assays also
indicated upregulation of the receptors for corresponding to specific
angiogenic factors such as IGF1 and VEGF-A. Real-time PCR assays
demonstrated at least a 2-fold increase in the expression of several
angiogenic factors in SD-MSCs from Day 30 of serum deprivation,
compared to MSCs that were harvested on Day 0 as described in
Pochampally et al. (2004). These factors included the family of
angiopoietins (ANGPTs) and VEGF-A (Fig. 2B). In addition, IGF-1 and
HGF, two growth factors with proangiogenic activity in ischemic
disease models [17,18], showed a greater than 55- and 9-fold
increase in SD-MSCs compared to MSCs, respectively (Fig. 2A). ELISAs
of conditioned media from SD-MSCs and MSCs confirmed significant
increases in VEGF-A and HGF, and demonstrated a greater than 4-
fold increase in levels of angiopoietin (Fig. 2C). IGF-1 levels were
below the lowest detectable levels in conditioned media from MSCs,
while conditioned media from SD-MSCs contained robust levels of
IGF-1 (Fig. 2C).
SD-MSCs display an endothelial cell-like phenotype
in vitro
Real-time PCR assays of SD-MSCs identified that a number of
endothelial-specific markers, such as VEGFR2, PECAM/CD31, and VE-
cadherin, were expressed in the transcriptome of SD-MSCs but were
below detectable levels in MSCs. In addition, the endothelial marker
Tie2/TEK was upregulated more than 2-fold in SD-MSCs compared to
MSCs (Fig. 3A). Immunocytochemistry confirmed the expression of
several of these endothelial markers, as well as eNOS, in asubpopulation of SD-MSCs (Fig. 3B). Next, we sought to determine
the origin of the cells exhibiting an endothelial phenotype, to
eliminate the possibility of contaminating hematopoietic cells. Flow
cytometric analysis demonstrated that SD-MSCs expressed the MSC
markers CD90, CD105, CD44, and CD166 and did not contain the
hematopoietic markers CD34, CD45, and CD11b [3,14] (Fig. 3C),
indicating that SD-MSCs exhibiting an endothelial phenotype are
derived from MSCs and not from contaminating hematopoietic cells.
Furthermore, approximately 15% of SD-MSCs expressed the endothelial
marker Tie2/TEK, while only 1–2% of MSCs expressed this epitope
(Fig. 3D). The endothelial cell marker expression preceded tubule
formation in the cultures. These experiments were repeated with at
least two MSC donor cells that were chosen to represent the
preparations that were most and least resistant to serum deprivation
(as described in Pochampally, 2004), in triplicates. Secondary antibody
only and isotype controls did not show any nonspecific staining (data
not shown).
Surprisingly, we observed that with prolonged culture in serum-
deprived medium, a population of SD-MSCs formed typical microtu-
bule patterns characteristic of microvessel formation by endothelial
cells (Fig. 4A). The structures were cell density dependent with very
little tubule formation at lower cell culture densities. In order to
substantiate the endothelial phenotype, we tested the ability of SD-
MSCs to take up acetylated low-density lipoprotein (ac-LDL), a
characteristic of endothelial cells [20]. After 30 days of serum
Figure 2 SD-MSCs express angiogenic factors: (A) Immunoblot of culturemedia conditioned by SD-MSCs on Day 30 of serumdeprivation.
(B) Relative expression of mRNA of secreted angiogenic factors in SD-MSCs from Day 30 of serum deprivation compared to donor-matched
MSCs, as determined by real-time PCR. Fold change in transcript levels is represented on the Y axis in a log scale. (C) ELISAs of growth
factors in conditionedmedia fromMSCs (Day 0) and SD-MSCs (Day 15 and Day 30). Values below theminimum detectable level of the assay
are marked with a #. The average of 4 culture replicates with SD is shown. * indicates a significant difference from Day 0 values (Pb0.01).
217Angiogenic properties of MSCsdeprivation, a subpopulation of cells displaying a tubular phenotype
was able to take up acetylated LDL, while cells with typical MSC
morphology (seen in Fig. 4A, Day 30 panel) did not incorporate ac-
LDL (Fig. 4B). To determine if the tubule formation seen in SD-MSC
cultures was the result of the culture microenvironment or the cells
themselves, MSCs and SD-MSCs were plated on grBME at equaldensity, and tested for tubule formation. The SD-MSCs showed
strong tubule formation within the first 24 h of plating, rapidly
forming an interconnected tubule network on the entire surface,
whereas MSCs showed only a weak tubular potential (Fig. 4C). Using
a technique described by Luesch et al. [21], we quantified the
degree of tube formation using branch point counting and pattern
Figure 3 SD-MSCs express both endothelial and mesenchymal markers. (A) Relative expression of mRNA for endothelial markers in
SD-MSCs on Day 30 of serum deprivation compared to MSCs. Samples below the threshold of detection are marked with a #, with fold
change calculated form the lowest detectable level of mRNA. (B) Immunofluorescent images of MSCs and SD-MSCs. Samples are
counterstained with DAPI (blue). Original magnification, 600×. (C) Flow cytometric analysis of cell surface proteins of MSCs and SD-
MSCs on Day 30 of serum deprivation. Open areas represent specified epitopes, gray areas represent isotype controls. Histograms
demonstrate event number (y axis) vs fluorescent intensity (x axis). (D) Flow cytometric analysis of Tie2/TEK for MSCs and SD-MSCs on
Day 30 of serum deprivation. A scatter plot of fluorescent intensity (y axis) vs forward scatter is shown.
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Figure 4 SD-MSCs exhibit endothelial cell phenotype. (A) Time course of tubule formation by MSCs cultured under serum-free
conditions. Original magnification 40×. (B) Uptake of FITC (green) labeled acLDL. SD-MSCs forming tubules on Day 30 of serum
deprivation take up acLDL labeled with FITC. There is no uptake of acLDL labeled with FITC by SD-MSCs with spindle morphology.
Original magnification 200×. (C) Representative images of SD-MSCs from Day 30 of serum deprivation and MSCs after 24 h on grBME.
Original magnification 100×. (D) Quantitation of branch points and tubule pattern from cells cultured on grBME for 24 h. The average of
8 culture replicates with SD is shown. * indicates a significant difference from Day 0 values (Pb0.05).
219Angiogenic properties of MSCsrecognition. SD-MSCs showed significantly more nodes, or connec-
tion points, per high-powered field. The number of connections at
each node was statistically similar between SD-MSCs and MSCs(Fig. 4D). Interestingly, after 30 days in serum-deprived media 10–
20% became spindle shaped and after 80 days of serum deprivation
these were the only remaining cells.
220 A. Oskowitz et al.SD-MSCs are highly angiogenic in vivoTo test the angiogenic potential of SD-MSCs in vivo, we developed a
modified version of the chick CAM assay. Plugs of grBME were
preincubated with cells and then placed on Day 7 chick CAMs.
Following a 7 day incubation, we observed that the angiogenic
potential of SD-MSCs was significantly higher than MSCs and the
vehicle control (Figs. 5A and B), based on analysis of CAM
neovascularization using a traditional 0–4 point scale [19].Figure 5 SD-MSCs are higly angiogenic in vivo. (A) Representative
of serum deprivation grown or vehicle control preincubated on grBME
is grBME without cells. (B) Angiogenic level of grBME-containing ce
samples, as judged by 2 blinded investigators, is displayed with SD.In order to test the functional significance of changes in the
secretome of SD-MSCs, we investigated the angiogenic potential of
conditioned media from MSCs and SD-MSCs using an ex vivo rat aortic
ring assay [19]. Conditioned medium from MSCs and SD-MSCs from
Day 15 of serum deprivation generated significantly longer vascular
sprouts from rat aortic rings than unconditioned media (control).
The vascular sprouts (measured in micrometers) from aortic rings
grown in SD-MSC-conditioned media were also significantly longer
than vascular sprouts from MSC-conditioned media (Figs. 6A and 6B).
As shown in Fig. 6B the length of sprouts ranged significantly.images of angiogenesis stimulated by MSCs, SD-MSCs from Day 30
and placed on a developing chick CAM for 7 days. Vehicle control
lls and control rated on a 0–4 scale. The average of at least 15
* Pb0.05, ** Pb0.005.
221Angiogenic properties of MSCsInterestingly, media from SD-MSCs that had been in a serum-
deprived state for 30 days degraded the fibrin clot surrounding the
rat aortic rings, making it impossible to assess the angiogenic
potential of conditioned media from these cells. These data are
consistent with real-time PCR data demonstrating an increase in
plasminogen and other proteases in SD-MSCs as compared to MSCs
(data not shown). Since many of the proangiogenic growth factors
and cytokines appear to continue to increase until Day 30 of serum
deprivation, these data likely underestimate the true angiogenic
potential of SD-MSCs.
To identify if the neovascular formation contained human cells
with endothelial markers, the CAMs were stained with a human-
specific antibody to PECAM/CD31. CAMs grown with SD-MSCs
demonstrated specific staining for human PECAM/CD31 in areas
with morphological characteristics of small vessels. CAMs grown with
MSCs showed a smaller number of cells staining positive for PECAM/
CD31. There was no cellular staining for human PECAM/CD31 in CAMs
grown with vehicle control grBME plugs (Figs. 7A and B), indicating
that the observed effect is specific to the SD-MSC phenotype and not
variation in cell permeability.Figure 6 (A) Representative images of vascular sprouts from rat aort
(Day 0) or conditionedmedia fromSD-MSCs (Day 15). All mediawere sup
in length of vascular sprouts between samples cultured with Day 0
measurements of vascular sprouts form6 culture replicates. Dataweren
a vehicle control group. The difference between measurement averag
vehicle control are displayed.DiscussionThese results demonstrate that subjecting early passage MSCs to
serum deprivation for 2–10 weeks selects for a distinct population of
cells that have high angiogenic potential. The SD-MSCs were
remarkable in that they not only survived complete serum
deprivation for prolonged periods of time, but also showed the
capacity to proliferate and secrete a significant amount of
prosurvival and angiogenic proteins. Interestingly, SD-MSCs exhibit
a characteristic biphasic growth curve indicating cell proliferation
followed by cell death to stabilize the cell density. This phenotype
was observed in more than 5 MSCs donor lines that were cultured
using the same culture conditions, controlling for cell density and
culture time.
Furthermore, conditioned media from SD-MSCs, and SD-MSCs
themselves, had a greater angiogenic potential than MSCs. Several
studies indicate that MSCs can reconstitute the hematopoietic
vascular niche in vivo when injected into ectopic sites [22,23] and
can establish their own microenvironment in vitro [24]. Thus, it isic rings cultured in SF-CCM (control), conditionedmedia fromMSCs
plementedwith 1% FCS. Original magnification 40×. (B) Difference
or Day 15 media and control. Data were generated from 110
ormalized for baseline vascular sproutingby comparing samples to
es from SD-MSCs (Day 15) and vehicle control or MSCs (Day 0) and
Figure 7 SD-MSCs express CD31 in vivo. (A) Representative immunofluorescent images of chick CAMs after growth with grBME-
containing MSCs, SD-MSCs on Day 30 of serum deprivation, or vehicle control. Merged color images are displayed for SD-MSCs (SD),
MSCs, and a vehicle control. (B) Composite image of chick CAM grown with SD-MSCs is also shown. Multiple images were taken at a
magnification of 100× and then combined to create an image displaying the entire CAM. Green represents staining with a human
specific CD31 antibody and blue represents DAPI staining.
222 A. Oskowitz et al.not surprising that in the absence of serum, MSCs secrete proteins
that promote survival and angiogenesis. Furthermore, conditioned
media from MSCs have been shown to have angiogenic potential in
vivo [9] and affect endothelial survival in vitro [25]. Several other
studies using ischemic disease models have shown that MSCs
promote endogenous angiogenesis via paracrine mechanisms [5–
7,9,13]. Specific secreted factors that were upregulated in SD-MSCs,
including VEGF-A, HGF, IGF-1, and ANGPTs, have been shown to be
important regulators of therapeutic angiogenesis following tissue
damage, although not unique to endothelial lineage [18,26–28].
A subset of SD-MSCs also expressed several new proteins
expressed by endothelial and hematopoietic cells that were not
expressed by control MSCs. However, lack of specific hematopoietic
cell marker expression negates the possibility of hematopoietic cell
contamination in the cell cultures. Several previous studies have
demonstrated that MSCs can differentiate into an endothelial
phenotype in vivo [8,12,13], and in vitro when cultured under low
serum conditions with supplemental VEGF [29]. Our data demon-
strate, quantitatively, that many of the endothelial markers that areexpressed under low serum conditions with exogenous VEGF-A are
upregulated in response to serum deprivation. We also demonstrate
that these cells lack other hematopoietic markers specifically
expressed on hematopoietic cells. This is important as endothelial
progenitor cells are believed to express thesemarkers [30] and share a
common lineage with hematopoietic cells [31,32]. The spontaneous
differentiation of over 80% of surviving SD-MSCs after 80 days into
tube-forming cells indicates that a subpopulation of SD-MSCs respond
to factors in the medium, and begin to display an endothelial
phenotype. Accordingly, we propose a model where MSCs placed
under serum-deprived conditions secrete an increased level of
prosurvival and angiogenic factors that can act in an autocrine,
paracrine, or juxtacrine manner to enhance angiogenesis (Fig. 8).
Our observations support recent interest in using both MSCs and
conditioned medium from MSCs to provide therapeutic benefits in
pathological vascular conditions including wound repair, ischemic
damage, microvascular permeability, and diabetes. In addition, the
observations presented here attempts to explain the role of paracrine
factors secreted by MSCs in the stromal property of MSCs. This study
Figure 8 Representative cartoon to show angiogenic properties of SD-MSCs.
223Angiogenic properties of MSCsalso has implications in understanding the vasculo-supportive property
of MSCs in poorly vascularized injury models such as solid tumors and
myocardial infarction models that will have regions that are subjected
to serum deprivation.
Methods
Cell culture
MSCs from bone marrow aspirates were obtained from the NIH funded
National Center for Research Resources (NCRR) Tulane Center for the
Preparation and Distribution of Adult Stem Cells at Tulane University.
The cells were obtained as frozen vials of passage 1 cells that were
shown to be multipotent for differentiation. The cells were negative
for hematopoietic markers (CD34, CD36, CD117, and CD45), and
positive for CD29 (95%), CD44 (N93%), CD49c (99%),CD49f (N70%), CD59
(N99%), CD90 (N99%), CD105 (N99%), and CD166 (N99%). All cultures
were incubated in complete culture medium (CCM): α-MEM (GIBCO/
BRL; Carlsbad, CA) containing 17% FBS (lot-selected for rapid growth of
MSCs; Atlanta Biologicals, Lawrenceville, GA), 100 μg/ml streptomycin
and 2 or 4 mM L-glutamine (both GIBCO/BRL) at 37 °C with 5%
humidified CO2, unless otherwise noted. Serum-deprived MSCS were
prepared by growing Passage 1 or 2 MSCs seeded at 1000 cells/cm2 to
70–80% confluence and replacing the CCM with α-MEM containing
100 μg/ml streptomycin (SF-CCM). Media were subsequently changed
every 3 days. The cells are harvested with trypsin/EDTA and counted
after trypan blue exclusion of dead cells. All the experiments were
performed with 2–5 donors that represent the most and least serum-
deprivation-resistant MSCs donors.
Immunoblots
For collection of conditioned media, SD-MSCs were washed three
times in PBS to remove nonadherent cells and debris, and then
incubated in fresh SF-CCM for a period of 24 h. The conditioned
media were collected and filtered to remove any cellular compo-nents. Fresh conditioned media were then tested for the presence of
specific proteins using the Human Angiogenesis Antibody array
(RayBiotech, Inc.; Norcross, GA) according to the manufacturer's
protocol. As control unconditioned media were used and no signal
was seen on the blot.Real-time PCR
Total RNA was extracted from MSCs or SD-MSCs using the RNeasy Mini
Kit (Qiagen; Valencia CA), and 500 ng was converted into cDNA with
the RT2 First Strand Kit (SuperArray Bioscience Corp.; Frederick, MD).
Real-time PCR was performed using the RT2 Angiogenesis PCR array
with the RT2 SYBR Green Master Mix (both SuperArray Bioscience
Corp.) according to the manufacturer's protocol. PCR arrays were run
with an ABI PRISM 7900HT Sequence Detection System (Applied
Biosystems; Foster City, CA) using the SDS 2.2 program. Fold change
in transcript levels were calculated using the ΔΔCt method of relative
quantification, by normalizing samples to the average of 5 endogenous
controls (β-2-microglobulin, β-actin, GAPDH, ribosomal protein L13a,
hypoxanthine phosphoribosyltransferase-1) and subsequently compar-
ing SD-MSC samples to MSC samples. Samples amplifying at a Ct value
greater than 35 were considered below the detectable range and the
value of 35 was used for fold change calculations.Immunocytochemistry
For immunofluorescence microscopy, cells grown on chamber slides
were washed in PBS and fixed in phosphate-buffered 4% (v/v)
paraformaldehyde for 15 min. Mouse anti-human CD31/PECAM (Clone
P2B1: Abcam; Cambridge, MA), mouse anti-Tie 2 (Clone 83715: R&D
Biosystems; Minneapolis, MN) rabbit anti-VEGFR2, or rabbit anti-eNOS
(bothAbcam)wereused as primary antibodies, and goat anti-mouse IgG
or goat anti-rabbit IgG conjugated to AlexaFluor488 or AlexaFluor594
(Molecular Probes; Carlsbad, Ca) were used as secondary antibodies.
Appropriate controls to include isotypes and secondary only were used
in parallel experiments. Images were acquired on an upright
224 A. Oskowitz et al.epifluorescent spinning disk confocal microscope (Hamamatsu EM-CCD
C9100;HamamatsuCity, Japan) using StereoInvestigator software (MBF
Bioscience, Williston, VT).Fluorescence-activated cell scanning
Approximately 200,000 MSCs or SD-MSCs were lifted with trypsin/
EDTA (0.25% Trypsin/1 mM EDTA; GIBCO/BRL) for 5 min at 37 °C.
Trypsin was then inactivated by adding an equal volume of FBS and
the cells were concentrated by centrifugation at 500 g for 5 min and
resuspended in 200 μl of PBS containing the appropriate fluores-
cently conjugated antibody. The following mouse monoclonal
antibodies were used: CD34 (Clone 581), CD45 (Clone J33), CD11b
(Clone Bear1), CD44 (Clone G44-26), CD166 (Clone 3A6), CD90 (Clone
Thy1/310), CD105 (Clone IG2) (all Beckman Coulter; Miami, FL), and
Tie2 (Clone 83715: R&D Systems). After a 20 min incubation period
cells were washed 3 times in PBS and assayed by FACScanning
(Cytomics FC 500; Beckman Coulter). All the experiments were
performed in triplicates and repeated with two or more MSC donors.In vitro angiogenesis assay
MSCs or SD-MSCs were lifted with trypsin/EDTA (0.25% trypsin/1 mM
EDTA; GIBCO/BRL) for 5 min at 37 °C. Trypsin was then inactivated by
adding an equal volume of FBS. The cells were concentrated by
centrifugation at 500 g for 5 min, resuspended in 200 μl of PBS, and
replated on growth factor-reduced basement membrane extract
(grBME), also called Matrigel (R&D Systems, http://www.rndsystems.
com/products.aspx) at 25000 cell/cm2 and cultured for 24 h. Images
were acquired on an upright spinning disk confocal microscope
(Hamamatsu EM-CCD C9100) using StereoInvestigator software (MBF
Bioscience). Tube formation was assessed blindly based on total
number of nodes/100x field and branch points/node.Rat aortic ring assay
For collection of conditioned media, MSCs or SD-MSCs were washed
three times in PBS to remove nonadherent cells and debris and then
incubated in fresh SF-CCM for a period of 24 h. The conditioned
media were collected and filtered to remove any cellular compo-
nents and were concentrated approximately 20-fold using a stirred
cell with a 1-kDa molecular weight cutoff ultrafiltration disk (both
Millipore; Billerica, MA). Samples were then normalized to total
protein content using the BCA Protein Assay for total protein
quantitation (Pierce; Rockford, IL). Nonconcentrated media had
undetectable levels of protein. Paragon Biosystems performed the
rat aortic ring assay using their standard protocol (Baltimore, MD).
Briefly, aortic rings from Wistar rats (1–2 months) were harvested,
embedded in fibrin clots, and placed in 24-well plates. The rings
were then incubated in conditioned media from SD-MSCs or MSCs
supplemented with 1% FBS or a vehicle control supplemented with
1% FBS. Six aortic rings were used for each experimental group as
well as the vehicle control. Media were changed every 48 h. After an
incubation period of 10 days the aortic rings were fixed with
phosphate-buffered 10% (v/v) formalin solution. Blinded microscop-
ic evaluations of the fixed rings were performed using an Olympus IX-
70 inverted microscope at 4X bright-field magnification. Ten random
measurements were made per half of each ring. Each measurement
reflected the radial length of one sprout in micrometers as
determined by computer-assisted image analysis. Digital images
were generated using a Retiga 2000R digital camera (QImaging,
Burnaby, BC). Image analysis was performed using Image-Pro Plus
5.1 (Media Cybernetics Inc., Silver Spring, MD).Chick CAM assay
Fertilized white leghorn chick embryos were obtained from Charles
River Laboratories (Wilmington, MA). Following 2 days of incubation
in a 39 °C humidified incubator with rocking, eggs were swabbed
with 70% ethanol, and 2 ml of albumin was withdrawn from the
smaller end of the egg with an 18-gauge needle. Two days later, the
air pocket in the larger end of the egg was ruptured with a 21-gauge
needle, and a window was cut in the side of the egg with a Dremel
tool to expose the chorioallantoic membrane (CAM).The windowwas
then resealed with tape. On Day 7 of incubation grBME (R&D
Systems) plugs with equal numbers of (0.2 to 2 million) SD-MSCs,
MSCs or vehicle control were added through the window and the
window was resealed with tape. After 7 additional days of incubation
(E15), the window was enlarged, and digital images of the CAM were
taken with a MiniVid digital camera (LW Scientific, Lawrenceville,
GA) and scored blindly on a scale of 0–4 for angiogenesis.Immunohistochemistry
For immunofluorescence microscopy, the area of the CAM surrounding
the plug was excised, embedded in Tissue-Tek OCT mounting medium
(Sakura; Zoeterwoude, The Netherlands), frozen, and sectioned.
Mouse anti-humanCD31/PECAM IgG (Clone P2B1: Abcam)was used at a
dilution of 1:100, and goat anti-mouse IgG AlexaFluor488 (Molecular
Probes) was used at 2 μg/ml. Images were acquired on an upright
spinning disk confocal microscope (Hamamatsu EM-CCD C9100) using
StereoInvestigator software (MBF Bioscience).Statistical analysis
Statistical analysis was performed using Microsoft Excel and with the
help of Analyse-it statistical analysis plug-in software (Analyse-it
Software, Ltd), when necessary. All P values noted were determined
using a two-sample method Student's t test, assuming unequal
variances, with P values generated for two tails. Sample size and
specific P values are noted in the figure legends. Confidence
intervals were generated using Dunnett's test for comparison of
samples to control.Acknowledgments
Some of the materials employed in this work were provided by the
Tulane Center for Gene Therapy through a grant fromNCRR of the NIH,
Grant P40RR017447 and Grants NIH AR 47796 and AR 48323, the
Oberkotter Foundation, the HCA the Health Care Company, and the
LouisianaGeneTherapyResearchConsortium toDr. Darwin J. Prockop.
We also thank Mr. Patrice Penfornis for technical assistance and
Margaret Wolf for critical review of the manuscript.References
Prockop, D.J., 1997]. Marrow stromal cells as stem cells for
nonhematopoietic tissues. Science 276, 71–74.
Owen, M., Friedenstein, A.J., 1988]. Stromal stem cells: marrow-
derived osteogenic precursors. Ciba Found. Symp. 136, 42–60.
Dominici, M., et al., 2006]. Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement 3. Cytotherapy 8, 315–317.
Kocher, A.A., et al., 2001]. Neovascularization of ischemic myocar-
dium by human bone-marrow-derived angioblasts prevents
cardiomyocyte apoptosis, reduces remodeling and improves
cardiac function. Nat. Med. 7, 430–436.
225Angiogenic properties of MSCsKinnaird, T., et al., 2004]. Local delivery of marrow-derived stromal
cells augments collateral perfusion throughparacrinemechanisms.
Circulation 109, 1543–1549.
Iwase, T., et al., 2005]. Comparison of angiogenic potency between
mesenchymal stem cells and mononuclear cells in a rat model of
hindlimb ischemia. Cardiovasc. Res. 66, 543–551.
Al-Khaldi, A., Al-Sabti, H., Galipeau, J., Lachapelle, K., 2003].
Therapeutic angiogenesis using autologous bone marrow stromal
cells: improved blood flow in a chronic limb ischemia model. Ann.
Thorac. Surg. 75, 204–209.
Lee, R.H., et al., 2006]. Multipotent stromal cells from human
marrow home to and promote repair of pancreatic islets and
renal glomeruli in diabetic NOD/scid mice. Proc. Natl Acad. Sci.
USA 103, 17438–17443.
Gnecchi, M., et al., 2005]. Paracrine action accounts for marked
protection of ischemic heart by Akt-modified mesenchymal stem
cells. Nat. Med. 11, 367–368.
Chopp, M., Li, Y., 2002]. Treatment of neural injury with marrow
stromal cells. Lancet Neurol. 1, 92–100.
Karnoub, A.E., et al., 2007]. Mesenchymal stem cells within tumour
stroma promote breast cancer metastasis. Nature 449, 557–563.
Wu, Y., Chen, L., Scott, P.G., Tredget, E.E., 2007]. Mesenchymal
stem cells enhance wound healing through differentiation and
angiogenesis. Stem Cells 25, 2648–2659.
Sasaki, M., et al., 2008]. Mesenchymal stem cells are recruited into
wounded skin and contribute to wound repair by transdiffer-
entiation into multiple skin cell type. J. Immunol. 180,
2581–2587.
Phinney, D.G., Prockop, D.J., 2007]. Concise review. Mesenchymal
stem/multipotent stromal cells: the state of transdifferentiation
and modes of tissue repair—current views. Stem Cells 25,
2896–2902.
Wang, M., Crisostomo, P.R., Herring, C., Meldrum, K.K., Meldrum,
D.R., 2006]. Human progenitor cells from bone marrow or
adipose tissue produce VEGF, HGF, and IGF-I in response to TNF
by a p38 MAPK-dependent mechanism. Am. J. Physiol. Regul.
Integr. Comp. Physiol. 291, R880–R884.
Pochampally, R.R., Smith, J.R., Ylostalo, J., Prockop, D.J., 2004].
Serum deprivation of human marrow stromal cells (hMSCs)
selects for a subpopulation of early progenitor cells with
enhanced expression of OCT-4 and other embryonic genes.
Blood 103, 1647–1652.
Aoki, M., et al., 2000]. Angiogenesis induced by hepatocyte growth
factor in non-infarcted myocardium and infarcted myocardium:
up-regulation of essential transcription factor for angiogenesis,
ets. Gene Ther. 7, 417–427.
Urbanek, K., et al., 2005]. Cardiac stem cells possess growth factor-
receptor systems that after activation regenerate the infarctedmyocardium, improving ventricular function and long-term
survival. Circ. Res. 97, 663–673.
Auerbach, R., Lewis, R., Shinners, B., Kubai, L., Akhtar, N., 2003].
Angiogenesis assays: a critical overview. Clin. Chem. 49, 32–40.
Voyta, J.C., Via, D.P., Butterfield, C.E., Zetter, B.R., 1984].
Identification and isolation of endothelial cells based on their
increased uptake of acetylated-low density lipoprotein. J. Cell
Biol. 99, 2034–2040.
Luesch, H., et al., 2006]. A functional genomics approach to the
mode of action of apratoxin A. Nat. Chem. Biol. 2, 158–167.
Sacchetti, B., et al., 2007]. Self-renewing osteoprogenitors in bone
marrow sinusoids can organize a hematopoietic microenviron-
ment. Cell 131, 324–336.
Bianco, P., Robey, P.G., 2001]. Stem cells in tissue engineering.
Nature 414, 118–121.
Ylostalo, J., Bazhanov, N., Prockop, D.J., 2008]. Reversible commit-
ment to differentiation by human multipotent mesenchymal stem
cells (MSCs) in single-cell derived colonies. Exp. Hematol. 36 (10),
1390–1402.
Hung, S.C., Pochampally, R.R., Chen, S.C., Hsu, S.C., Prockop, D.J.,
2007]. Angiogenic effects of human multipotent stromal cell
conditioned medium activate the PI3K-Akt pathway in hypoxic
endothelial cells to inhibit apoptosis, increase survival, and
stimulate angiogenesis. Stem Cells 25, 2363–2370.
Sadat, S., et al., 2007]. The cardioprotective effect of mesenchymal
stem cells is mediated by IGF-I and VEGF. Biochem. Biophys. Res.
Commun. 363, 674–679.
Matsumoto, R., et al., 2005]. Vascular endothelial growth factor-
expressing mesenchymal stem cell transplantation for the
treatment of acute myocardial infarction. Arterioscler. Thromb.
Vasc. Biol. 25, 1168–1173.
Shim, W.S., et al., 2006]. Angiopoietin-1 promotes functional
neovascularization that relieves ischemia by improving regional
reperfusion in a swine chronic myocardial ischemia model. J.
Biomed. Sci. 13, 579–591.
Oswald, J., et al., 2004]. Mesenchymal stem cells can be
differentiated into endothelial cells in vitro. Stem Cells 22,
377–384.
Asahara, T., et al., 1997]. Isolation of putative progenitor
endothelial cells for angiogenesis. Science 275, 964–967.
Kabrun, N., et al., 1997]. Flk-1 expression defines a population of
early embryonic hematopoietic precursors. Development 124,
2039–2048.
Nishikawa, S.I., Nishikawa, S., Hirashima, M., Matsuyoshi, N.,
Kodama, H., 1998]. Progressive lineage analysis by cell sorting
and culture identifies FLK1+VE-cadherin+cells at a diverging
point of endothelial and hemopoietic lineages. Development
125, 1747–1757.
